LOX and breast cancer: More specifically, it has been shown that HIF-1α may induce an enhanced expression of lysyl oxidase (LOX), lysyl oxidase-like 2 (LOXL2) and LOXL4 in hypoxic breast cancer cells within primary breast tumour [125, 257].